Vaccine Mandates and Roads Not Taken
Another regulatory approach to mandate vaccines could have withstood judicial scrutiny.
The Biden-Harris Administration’s Racial Equity Efforts
Although much more work remains, the current Administration has made historic progress in advancing equity.
What It Means to Support a Waiver of COVID-19 Vaccine Patents
The Biden Administration should exert international and domestic pressure to waive COVID-19 vaccine patents.
The Biden Executive Order on Restructuring Competition
Antitrust experts from the University of Pennsylvania reflect on the possible consequences of the recent Biden executive order on competition.
The Absence of Black Financial Regulators
Scholar argues that U.S. financial regulatory agencies must reflect the people they serve.
Shaping Administrative Process and Metrics of Ambition
President Biden’s first executive actions provide lessons on presidential authority and ambition.
Lessons in Presidential Authority
President Trump’s last executive actions and President Biden’s early ones reveal fleeting nature of executive power.
The Irrationality of Market Failure Theory
The economic principles underlying cost-benefit analysis exclude future impacts.
The Justice Department Should Preserve Home Confinement
The Biden Administration should reject arguments to re-incarcerate people released from prison during the COVID-19 pandemic.
The Biden memorandum signals continuity in some areas of regulatory practice and dramatic shifts in others.
Flipping the Mission of Regulatory Review
President Biden’s memo could transform the mission of regulatory review by expanding OIRA’s role.
Rejecting the Trump Anticanon of Regulatory Mismanagement
The Biden memo on improving regulatory review reintroduces competent, bipartisan cost-benefit analysis.